March 24, 2020
Olympus is continually monitoring the global developments around the COVID-19 pandemic and has set up a global task force to ensure business continuity. The health and safety of our employees, customers and the patients they treat, and communities are extremely important to us. We are doing everything we can do to maintain supplies while also being vigilant about the risk. We are paying special attention to partners in the healthcare industry, who are at the center of working to address this global crisis. Although we do not foresee any short-term impact at this time, we are continually assessing our situation and will promptly inform stakeholders about changes whenever appropriate.
While offices in China slowly start resuming regular operation, many offices in other Asian countries, Americas and in EMEA are working in shifts and/or from home where applicable. Manufacturing sites, field force and repair centers have taken precautionary measures but continue operating regularly until further notice. To minimize employees’ potential exposure to this virus, Olympus globally made the decision to restrict all international business travel for the time being. This travel restriction will remain in place until further notice and restrictions are subject to change based on the evolving situation.
We recognize that government guidance around the world varies by location and in some instances is stricter than Olympus’ global guidance. In those cases, the local guidance takes precedence.
We are fully committed to keep all stakeholders up to date as needed and strictly follow guidance by national authorities, leading associations or the Financial Instruments Exchange in Japan.
Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.